Join our mailing list!

Official PayPal Seal

(Your shopping cart is empty)

  Home > Diane Publishing Books >

FDA, Merck, and Vioxx: Putting Patient Safety First?: Hearing before the Committee on Finance, U.S. Senate
Witnesses: David J. Graham, Assoc. Dir. for Scienc

Our Price: $75.00
By Charles E. Grassley (ed)
Year: 2004
Pages: 921
Binding Paperback

Product Code: 1422304876

Witnesses: David J. Graham, Assoc. Dir. for Science, Office of Drug Safety, Center for Drug Evaluation & Research, Food & Drug Admin. (FDA); Sandra L. Kweder, Acting Dir., Office of New Drugs, Center for Drug Evaluation & Research, FDA; Bruce M. Psaty, Prof., Medicine & Epidemiology, Univ. of Wash., Cardiovascular Health Research Unit, Seattle, WA; Gurkipal Singh, Adjunct Clinical Prof. of Medicine, Div. of Gastroenterology & Hematology, Dept. of Medicine, Stanford Univ. School of Medicine; & Raymond V. Gilmartin, chmn., Pres. & CEO, Merck & Co., Whitehouse Station, NJ. Also includes: opening statements by members of the Comm. on Finance, U.S. Senate; & a communication from Eric J. Topol. Illustrations.

Share your knowledge of this product with other customers... Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
 About Us
 Become an Affiliate
 Privacy Policy
 Send Us Feedback
Company Info | Advertising | Product Index | Category Index | Help | Terms of Use
Copyright � 2004 Diane Publishing Company. All Rights Reserved.
Built with Volusion